BioCentury | Dec 8, 2017
Company News

Genisphere and INSERM partner to develop neurological nanotherapies

...National de la Sante et de la Recherche Medicale (INSERM) to investigate the use of nanotherapeutics...
BioCentury | Jun 21, 2017
Company News

Management tracks

...was chairman, president and CEO of EPS Holdings Inc. (Tokyo:4282). Contract development and manufacturing company Nanotherapeutics...
BioCentury | Dec 17, 2015
Translation in Brief

Oh, the places you'll go

...noted that nanoparticle dynamics are a function of particle engineering as well. "As you develop nanotherapeutics...
BioCentury | Sep 28, 2015
Company News

Nanotherapeutics, Takeda deal

...The partners will expand Takeda’s commercialization and technology access rights related to Nanotherapeutics’ Vero cell culture...
...rights to the technology to develop an H5N1 influenza vaccine under a December 2010 deal. Nanotherapeutics...
...disclose financial details, and Nanotherapeutics did not respond to inquiries (see BioCentury, Dec. 6, 2010). Nanotherapeutics...
BioCentury | Mar 23, 2015
Financial News

Nanotherapeutics financial update

...Nanotherapeutics Inc. , Alachua, Fla. Business: Drug delivery, Musculoskeletal Date announced: 2015-03-17 Note: Nanotherapeutics secured a...
BioCentury | Oct 6, 2014
Company News

PharmAthene, Nanotherapeutics, U.S. Department of Defense deal

...PharmAthene partnered with Nanotherapeutics to advance undisclosed biodefense products from both companies' portfolios. The partners said...
...of products to prevent and treat emerging infectious diseases and biodefense threats fits well with Nanotherapeutics'...
...in 2015. Nanotherapeutics has manufacturing capabilities in its existing facility. PharmAthene Inc. (NYSE-M:PIP), Annapolis, Md. Nanotherapeutics...
BioCentury | Jun 9, 2014
Financial News

Nanotherapeutics Inc. financial update

...Nanotherapeutics secured a $30 million loan facility from Hercules Technology Growth Capital. Nanotherapeutics Inc. , Alachua...
BioCentury | Oct 7, 2013
Company News

Cook Group, JHP Pharmaceuticals, Nanotherapeutics, Royal DSM, U.S. Department of Health and Human Services infectious news

...Biomedical Advanced Research and Development Authority (BARDA) awarded contracts to Cook's Cook Pharmica subsidiary, JHP, Nanotherapeutics...
...are in development. Cook Group Inc. , Bloomington, Ind. JHP Pharmaceuticals LLC , Parsippany, N.J. Nanotherapeutics...
BioCentury | Dec 10, 2012
Company News

Genisphere, Lankenau Institute deal

...Genisphere and the non-profit added the development of nanotherapeutics targeting cancer and ophthalmic diseases to an...
BioCentury | Oct 24, 2011
Product Development

Alzheimer's rewind

...antagonist Ph II H. Lundbeck A/S (CSE:LUN) Lu AE58054 Serotonin (5-HT6) receptor antagonist Ph II Nanotherapeutics...
Items per page:
1 - 10 of 79